Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Design Therapeutics (DSGN) Shares Outstanding (2020 - 2021)

Historic Shares Outstanding for Design Therapeutics (DSGN) over the last 2 years, with Q3 2021 value amounting to $55.2 million.

  • Design Therapeutics' Shares Outstanding rose 24760.0% to $55.2 million in Q3 2021 from the same period last year, while for Sep 2021 it was $55.2 million, marking a year-over-year increase of 24760.0%. This contributed to the annual value of $16.0 million for FY2020, which is N/A changed from last year.
  • As of Q3 2021, Design Therapeutics' Shares Outstanding stood at $55.2 million, which was up 24760.0% from $55.1 million recorded in Q2 2021.
  • In the past 5 years, Design Therapeutics' Shares Outstanding ranged from a high of $55.2 million in Q3 2021 and a low of $15.7 million during Q1 2020